hydroxyproline and Forestier-Certonciny Syndrome studies

hydroxyproline and Forestier-Certonciny Syndrome

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research Excerpts

Excerpt	Relevance	Reference
"Steroids are the only treatment of polymyalgia rheumatica (PMR)."	6.68	Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. ( Bartoli, E; Casatta, L; De Vita, S; Ferraccioli, G; Salaffi, F, 1996)
"Steroids are the only treatment of polymyalgia rheumatica (PMR)."	2.68	Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. ( Bartoli, E; Casatta, L; De Vita, S; Ferraccioli, G; Salaffi, F, 1996)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

1 (50.00)

18.7374

1990's

1 (50.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Ferraccioli, G	1
Salaffi, F	1
De Vita, S	1
Casatta, L	1
Bartoli, E	1
Deding, A	1
Tougaard, L	1
Krogh Jensen, M	1
Rodbro, P	1

Studies

Ferraccioli, G

Salaffi, F

De Vita, S

Casatta, L

Bartoli, E

Deding, A

Tougaard, L

Krogh Jensen, M

Rodbro, P

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794]	Phase 3	94 participants (Anticipated)	Interventional	2019-03-01	Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

A Multicenter Randomized Placebo Controlled Treatment Study of Leflunomide in Polymyalgia Rheumatica[NCT03576794]

Phase 3

94 participants (Anticipated)

Interventional

2019-03-01

Recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for hydroxyproline and Forestier-Certonciny Syndrome

Article	Year
Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study. The Journal of rheumatology, 1996, Volume: 23, Issue:4 Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Blood Sedimentation; Bone Density; C-Reactive	1996

Article

Year

Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.

The Journal of rheumatology, 1996, Volume: 23, Issue:4

Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Blood Sedimentation; Bone Density; C-Reactive

1996

Other Studies

1 other study available for hydroxyproline and Forestier-Certonciny Syndrome

Article	Year
Bone changes during prednisone treatment. Acta medica Scandinavica, 1977, Volume: 202, Issue:4 Topics: Aged; Bone and Bones; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Hydroxyproline; Leukemi	1977

Article

Year

Bone changes during prednisone treatment.

Acta medica Scandinavica, 1977, Volume: 202, Issue:4

Topics: Aged; Bone and Bones; Drug Evaluation; Female; Giant Cell Arteritis; Humans; Hydroxyproline; Leukemi

1977